BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36422528)

  • 1. Commercially Available Enteric Empty Hard Capsules, Production Technology and Application.
    Franc A; Vetchý D; Fülöpová N
    Pharmaceuticals (Basel); 2022 Nov; 15(11):. PubMed ID: 36422528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Comparison of Various Coated Hard Capsules Suitable for Enteric Administration to Small Patient Cohorts.
    Fülöpová N; Pavloková S; DeBono I; Vetchý D; Franc A
    Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 36015203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of protection and release behavior of different capsule polymer combinations based on L. acidophilus survivability and function and caffeine release.
    Marzorati M; Calatayud M; Rotsaert C; Van Mele M; Duysburgh C; Durkee S; White T; Fowler K; Jannin V; Bellamine A
    Int J Pharm; 2021 Sep; 607():120977. PubMed ID: 34384885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical development of enteric-release hard gelatin capsules in the compounding setting.
    Ferreira Ade O; Holandino C
    Int J Pharm Compd; 2008; 12(2):163-9. PubMed ID: 23969610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Capsule-in-Capsule Combinations on In Vivo Disintegration in Human Volunteers: A Combined Imaging and Salivary Tracer Study.
    Rump A; Weiss FN; Schulz L; Kromrey ML; Scheuch E; Tzvetkov MV; White T; Durkee S; Judge KW; Jannin V; Bellamine A; Weitschies W; Grimm M
    Pharmaceutics; 2021 Nov; 13(12):. PubMed ID: 34959284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring Immersion Coating as a Cost-Effective Method for Small-Scale Production of Enteric-Coated Gelatin Capsules.
    Sabbatini B; Perinelli DR; Palmieri GF; Cespi M; Bonacucina G
    Pharmaceuticals (Basel); 2024 Mar; 17(4):. PubMed ID: 38675394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Industrial Manufacture of Enteric Hard Capsules Using Novel Formulations Based on Hypromellose Phthalate/Gelatin and Investigation of Pantoprazole Release.
    Kalmer RR; Haddadan MM; Azizi M; Ghanbari M; Samandarian D; Sadjadinia A; Ramezanalizadeh H; Karimi A; Golizadeh M
    ACS Omega; 2023 Mar; 8(12):11293-11303. PubMed ID: 37008088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achieving gastroresistance without coating: Formulation of capsule shells from enteric polymers.
    Barbosa JAC; Al-Kauraishi MM; Smith AM; Conway BR; Merchant HA
    Eur J Pharm Biopharm; 2019 Nov; 144():174-179. PubMed ID: 31541663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus.
    Garbacz G; Cadé D; Benameur H; Weitschies W
    Eur J Pharm Sci; 2014 Jun; 57():264-72. PubMed ID: 24021609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A developed composite hard-gelatin capsules: delayed-release enteric properties.
    Nezhad Mohseni M; Najafpour Darzi G; Ramezani R; Jahani A
    Heliyon; 2022 Dec; 8(12):e12265. PubMed ID: 36619422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of QbD principles for the evaluation of empty hard capsules as an input parameter in formulation development and manufacturing.
    Stegemann S; Connolly P; Matthews W; Barnett R; Aylott M; Schrooten K; Cadé D; Taylor A; Bresciani M
    AAPS PharmSciTech; 2014 Jun; 15(3):542-9. PubMed ID: 24526655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of the gastrointestinal delivery of acid-sensitive pancrelipase in a next generation enteric capsule using an exocrine pancreatic insufficiency disease model.
    Jannin V; Duysburgh C; Gonzalez V; Govaert M; Agisson M; Marzorati M; Madit N
    Int J Pharm; 2023 Jan; 630():122441. PubMed ID: 36442722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Physicochemical Properties and Capsule Fill Determine Extent of Premature Gastric Release from Enteric Capsules.
    Moghrabi FS; Fadda HM
    Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36432696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo Evaluation of a Gastro-Resistant HPMC-Based "Next Generation Enteric" Capsule.
    Rump A; Kromrey ML; Scheuch E; Jannin V; Rehenbrock L; Tzvetkov MV; Weitschies W; Grimm M
    Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteric Hard Capsules for Targeting the Small Intestine: Positive Correlation between In Vitro Disintegration and Dissolution Times.
    Fu M; Al-Gousous J; Blechar JA; Langguth P
    Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32028731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of Reliable Gastro-Resistance of Novel Enteric Ready-to-Fill Capsules Simplifying Pharmaceutical Manufacturing.
    Afonso Urich JA; Fedorko A; Hölzer B; Khinast J
    Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymer film formulations for the preparation of enteric pharmaceutical capsules.
    Smith AM; Ingham A; Grover LM; Perrie Y
    J Pharm Pharmacol; 2010 Feb; 62(2):167-72. PubMed ID: 20487195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro release characteristics of hard shell capsule products coated with aqueous- and organic-based enteric polymers.
    Murthy KS; Kubert DA; Fawzi MB
    J Biomater Appl; 1988 Jul; 3(1):52-79. PubMed ID: 3199314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of enteric capsules by means of hot-melt extrusion.
    Mehuys E; Remon JP; Vervaet C
    Eur J Pharm Sci; 2005 Feb; 24(2-3):207-12. PubMed ID: 15661492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.